AU2002351768A1 - Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors - Google Patents

Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors

Info

Publication number
AU2002351768A1
AU2002351768A1 AU2002351768A AU2002351768A AU2002351768A1 AU 2002351768 A1 AU2002351768 A1 AU 2002351768A1 AU 2002351768 A AU2002351768 A AU 2002351768A AU 2002351768 A AU2002351768 A AU 2002351768A AU 2002351768 A1 AU2002351768 A1 AU 2002351768A1
Authority
AU
Australia
Prior art keywords
biphenylcarboxamides
oxadiazolyl
kinase inhibitors
kinase
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351768A
Inventor
Richard Martyn Angell
Paul Bamborough
George Stuart Cockerill
Kathryn Jane Smith
Ann Louise Walker
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of AU2002351768A1 publication Critical patent/AU2002351768A1/en
Abandoned legal-status Critical Current

Links

AU2002351768A 2001-10-17 2002-10-16 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors Abandoned AU2002351768A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0124932.5 2001-10-17

Publications (1)

Publication Number Publication Date
AU2002351768A1 true AU2002351768A1 (en) 2003-04-28

Family

ID=

Similar Documents

Publication Publication Date Title
AU2002362895A1 (en) 5-carbamoyl-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
AU2002346929A1 (en) 5-acylamino-1,1-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2728201A (en) 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
AU2001237041A1 (en) Kinase inhibitors
MXPA03006420A (en) Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase.
AU2003237446A1 (en) Pyrazole-derivatives as p38 kinase inhibitors
AU2002356762A1 (en) 4-arylquinazolines and use thereof as nhe-3 inhibitors
PL372620A1 (en) New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
AU2001270260A1 (en) 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
AU2002361577A1 (en) Tyrosine kinase inhibitors
AU2002226911A1 (en) Indol derivative and their use as inhibitors of p38 kinase
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2003256410A1 (en) COMBINATION THERAPY WITH p38 MAP KINASE INHIBITORS AND THEIR PHARMACEUTICAL COMPOSITIONS
AU2002348394A1 (en) Tyrosine kinase inhibitors
AU2003220437A1 (en) Thiopyrimidine and isothiazolopyrimidine kinase inhibitors
AU2002348020A1 (en) Tyrosine kinase inhibitors
AU2002348393A1 (en) Tyrosine kinase inhibitors
AU2002237657A1 (en) Indole-type inhibitors of p38 kinase
AU2002323406A1 (en) Tyrosine kinase inhibitors
AU2002327534A1 (en) Tyrosine kinase inhibitors
AU2002253350A1 (en) 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors
AU2001279090A1 (en) Heterocyclic-hydroxyimino-fluorenes and their use for inhibiting protein kinases
EP1631145A4 (en) P38 kinase inhibitor compositions and methods of using the same
AU2002351768A1 (en) Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors